Home / News
-
-
On November 28th China Biologics public release said that the company's anti-neoconazole monoclonal antibody F61 nasal spray developed by the company was approved for clinical use.2022-11-29View More
-
-
Liquid biopsy firm SeekIn said Monday that it has received a CE mark for its cancer recurrence monitoring test, SeekInCure, and is preparing to launch assay kits in the European Union and other countries that recognize the designation.2022-11-29View More
-
-
Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system to fight them.2022-11-29View More
-
-
According to the WeChat public account of Peking Union Medical College Hospital on November 21, the peripheral blood cell image leukocyte assisted recognition software jointly developed by the Laboratory Department of Peking Union Medical College Hospital and Beijing Xiaofly Technology passed2022-11-28View More
-
-
Cue Health on Wednesday afternoon announced that revenues for the third quarter beat both Wall Street expectations and previous guidance from the firm.2022-11-28View More
-
-
DNAscope, a germline variant-calling pipeline from San Jose-based analytics firm Sentieon, achieved superior SNP and indel accuracy as compared to other standard datasets, according to a recent preprint from the company.2022-11-28View More
-
-
The 86th China International Medical Equipment Fair (CMEF) was suspended in consideration of the health and safety of all participants.2022-11-25View More
-
-
A slower-than-expected recovery in certain procedures, including TAVR and spinal cord stimulation, curbed quarterly profit and revenue.2022-11-25View More
-
-
Avacta, a UK-based developer of cancer immunotherapies and diagnostics, said on Tuesday that it has signed an agreement to acquire Launch Diagnostics for up to ¡ê37 million ($41.9 million).2022-11-25View More
-
-
Lab testing supply firm Biocare Medical said Tuesday that it has acquired Empire Genomics, a provider of molecular probes for cancer research and diagnostics development, for an undisclosed amount.2022-11-24View More
-
-
The US Food and Drug Administration last week granted Emergency Use Authorization for Premier Medical Laboratory Services' Diversified Medical Healthcare SARS-CoV-2 Assay.2022-11-24View More
-
-
The COVID-19 Antigen Home Test manufactured by Assure Tech has been validated by laboratory and clinical studies to meet FDA standards and has been granted EUA. This means that the product can be marketed in the USA and in countries that recognise FDA EUA approval.2022-11-23View More
-
-
Meridian Bioscience reported on Tuesday that its fiscal fourth quarter revenues declined 14 percent year over year.2022-11-23View More
-
-
The US Food and Drug Administration on Tuesday granted Emergency Use Authorization for a molecular COVID-19/flu test from Lucira Health.2022-11-23View More
-
-
The reason why Daan Gene took the initiative to cut the prices of several test reagents is that the market demand for such test reagents has not yet reached a large scale, and it is doubtful whether it is feasible to exchange price for volume.2022-11-22View More
-
-
Agilent Technologies said after the close of the market on Monday that its fiscal fourth quarter revenues grew 11 percent year over year and beat the consensus Wall Street estimate.2022-11-22View More
-
-
Al Jalila Children's Specialty Hospital, based in Dubai, United Arab Emirates, said on Monday that it has signed a deal with Illumina to collaborate on rapid whole-genome sequencing for diagnosing critically ill children.2022-11-22View More
-
-
The overall overseas revenue of listed china companies has a three-year CAGR of more than 25%, and the export volume will rebound significantly in 2022.2022-11-21View More
-
-
ANP Technologies has received Emergency Use Authorization from the US Food and Drug Administration for its NIDS COVID-19 Antigen Home Test, according to the agency said on Thursday.2022-11-21View More
-
-
Innova Medical Group and iXensor said Thursday they have reached a distribution deal covering Europe for the Phronesia Smart Ovulation Test, an Innova-branded assay using iXensor's technology.2022-11-21View More
- CAIVD WeChat
Subscription Account
- CAIVD WeChat
Channels
China Association of In-vitro Diagnostics
Part of the information in our website is from the internet.
If by any chance it violates your rights, please contact us.